Cynosure Group LLC Has $403,000 Stock Position in Addus HomeCare Corporation $ADUS

Cynosure Group LLC lessened its holdings in Addus HomeCare Corporation (NASDAQ:ADUSFree Report) by 75.8% during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,495 shares of the company’s stock after selling 10,920 shares during the quarter. Cynosure Group LLC’s holdings in Addus HomeCare were worth $403,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Private Advisor Group LLC lifted its position in shares of Addus HomeCare by 52.4% during the 1st quarter. Private Advisor Group LLC now owns 2,546 shares of the company’s stock worth $252,000 after buying an additional 875 shares during the last quarter. Universal Beteiligungs und Servicegesellschaft mbH bought a new position in shares of Addus HomeCare in the first quarter worth about $2,450,000. Avantax Advisory Services Inc. boosted its stake in shares of Addus HomeCare by 38.9% in the 1st quarter. Avantax Advisory Services Inc. now owns 3,255 shares of the company’s stock valued at $322,000 after purchasing an additional 911 shares in the last quarter. Premier Fund Managers Ltd bought a new stake in shares of Addus HomeCare during the 1st quarter valued at approximately $726,000. Finally, XTX Topco Ltd acquired a new position in Addus HomeCare during the 1st quarter worth approximately $804,000. Institutional investors own 95.35% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on ADUS shares. Cowen restated a “buy” rating on shares of Addus HomeCare in a research report on Wednesday, November 5th. Weiss Ratings reissued a “hold (c+)” rating on shares of Addus HomeCare in a report on Wednesday, October 8th. Stephens restated an “overweight” rating and set a $140.00 price objective on shares of Addus HomeCare in a research report on Wednesday, September 3rd. UBS Group assumed coverage on Addus HomeCare in a report on Tuesday, September 2nd. They issued a “buy” rating and a $145.00 target price for the company. Finally, BMO Capital Markets initiated coverage on Addus HomeCare in a research report on Thursday, November 13th. They issued a “market perform” rating and a $120.00 target price for the company. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $137.11.

Get Our Latest Analysis on Addus HomeCare

Addus HomeCare Stock Up 2.8%

Shares of NASDAQ:ADUS opened at $115.90 on Tuesday. The firm has a market cap of $2.14 billion, a P/E ratio of 25.58, a P/E/G ratio of 1.87 and a beta of 0.88. Addus HomeCare Corporation has a 12-month low of $88.96 and a 12-month high of $136.72. The business has a fifty day simple moving average of $115.02 and a 200 day simple moving average of $113.28. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.17.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last issued its quarterly earnings results on Monday, November 3rd. The company reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.53 by $0.03. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%.The company had revenue of $362.30 million during the quarter, compared to analysts’ expectations of $354.48 million. During the same quarter in the prior year, the firm posted $1.30 earnings per share. The business’s quarterly revenue was up 25.0% on a year-over-year basis. Analysts predict that Addus HomeCare Corporation will post 4.59 earnings per share for the current year.

Insider Activity

In other news, EVP Darby Anderson sold 20,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 19th. The shares were sold at an average price of $109.00, for a total value of $2,180,000.00. Following the transaction, the executive vice president owned 44,144 shares in the company, valued at approximately $4,811,696. The trade was a 31.18% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 4.50% of the company’s stock.

Addus HomeCare Company Profile

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

See Also

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUSFree Report).

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.